Clinical Drug Experience Knowledgebase

Acute Lung Injury (Phase 3)

Amblyopia (Phase 4)

Bipolar Disorder (Phase 4)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Carcinoma, Renal Cell (Phase 2)

Cardiovascular Diseases (Phase 3)

Communicable Diseases (Phase 2)

Coronary Disease (Phase 3)

Death, Sudden (Phase 3)

Death, Sudden, Cardiac (Phase 3)

Disease (Phase 4)

Heart Arrest (Phase 3)

Heart Diseases (Phase 3)

Hemoptysis (Phase 2)

HIV Infections (Phase 2)

Hypertension (Phase 3)

Infections (Phase 2)

Inflammation (Phase 3)

Kidney Neoplasms (Phase 2)

Leukemia (Phase 1)

Lung Diseases (Phase 3)

Lung Neoplasms (Phase 2)

Lymphoma (Phase 1)

Multiple Myeloma (Phase 2)

Multiple Organ Failure (Phase 4)

Myelodysplastic Syndromes (Phase 1)

Myeloproliferative Disorders (Phase 1)

Myocardial Infarction (Phase 3)

Myocardial Ischemia (Phase 3)

Myopia (Phase 3)

Neoplasms (Phase 1)

Neoplasms, Plasma Cell (Phase 2)

Obesity (Phase 3)

Plasmacytoma (Phase 2)

Precancerous Conditions (Phase 1)

Preleukemia (Phase 1)

Psychotic Disorders (Phase 4)

Respiratory Distress Syndrome (Phase 3)

Respiratory Distress Syndrome, Newborn (Phase 3)

Respiratory Tract Infections (Phase 2)

Schizophrenia (Phase 4)

Stomach Neoplasms (Phase 2)

Syndrome (Phase 3)

Tobacco Use Disorder (Phase 4)

Ventricular Fibrillation (Phase 3)